- Home
- BBNX vs QDEL Comparison
BBNX vs QDEL Comparison
Compare BBNX & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBNX | QDEL |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.9M | 989.5M |
| IPO Year | 2025 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BBNX | QDEL |
|---|---|---|
| Price | $22.19 | $10.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | $23.80 | ★ $28.25 |
| AVG Volume (30 Days) | 1.2M | ★ 1.2M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.95 | 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | $100,251,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $34.90 | $3.51 |
| Revenue Next Year | $34.63 | $3.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 53.94 | N/A |
| 52 Week Low | $8.80 | $9.92 |
| 52 Week High | $32.71 | $35.58 |
Technical Indicators
Market Signals| Indicator | BBNX | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 33.09 |
| Support Level | N/A | $9.92 |
| Resistance Level | N/A | $12.85 |
| Average True Range (ATR) | 0.00 | 0.64 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 0.00 | 12.62 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.